Erythroblastosis virus oncogene B (erbB)
Showing 1 - 25 of >10,000
Breast Tumors, Malignant Tumor of Breast Trial in Dallas (Trastuzumab, Ibrutinib 560 mg, Ibrutinib 840 mg)
Recruiting
- Breast Neoplasms
- Malignant Neoplasm of Breast
- Trastuzumab
- +3 more
-
Dallas, Texas10 sites incl TX, WA, VA, and NV
May 16, 2022
Carcinoma Breast Stage I, HER2 Positive Breast Cancer Trial in Mumbai (Trastuzumab, Placebo)
Recruiting
- Carcinoma Breast Stage I
- HER2 Positive Breast Cancer
- Trastuzumab
- Placebo
-
Mumbai, IndiaTata Memorial Centre
Apr 26, 2022
Breast Cancer Trial in Tampa (Selinexor)
Completed
- Breast Cancer
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Sep 9, 2020
Lung Cancer, Non Small Cell Lung Cancer Trial in Aurora (Amivantamab 1050mg, Amivantamab 1400mg, Amivantamab (to be determined))
Not yet recruiting
- Lung Cancer
- Non Small Cell Lung Cancer
- Amivantamab 1050mg
- +2 more
-
Aurora, Colorado
- +2 more
Apr 25, 2023
BRAF V600E, Metastatic Colorectal Cancer Trial in China (Encorafenib, Cetuximab, FOLFIRI)
Recruiting
- BRAF V600E
- Metastatic Colorectal Cancer
- Encorafenib
- +2 more
-
Beijing, Beijing, China
- +33 more
Dec 20, 2022
Gut Microbiome in People Living With HIV and HBV
Not yet recruiting
- Human Immunodeficiency Virus
- +2 more
- (no location specified)
Nov 8, 2023
Hepatitis B, Osteoporosis, Osteoporosis Risk Trial (Patient Participation Form)
Not yet recruiting
- Hepatitis B
- +2 more
- Patient Participation Form
- (no location specified)
Mar 3, 2023
T-bet B Cells in Persistent Virus Control After Discontinuance
Completed
- Chronic HBV Infection
- Drug Withdrawal
- T-bet B cell
-
Shanghai, ChinaChanghai hospital
Sep 1, 2023
Thrombocytopenia Purpura, Chronic HBV Infection Trial in Tianjin (Eltrombopag)
Completed
- Thrombocytopenia Purpura
- Chronic HBV Infection
-
Tianjin, Tianjin, ChinaEthics Committee of Blood disease hospital, Chinese Academy of M
Jan 24, 2023
Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma Trial in United States
Active, not recruiting
- Stage III Cutaneous Melanoma AJCC v7
- +2 more
- Computed Tomography
- +3 more
-
Birmingham, Alabama
- +759 more
Aug 18, 2022
Tenofovir Disoproxil Fumarate and Entcavir in Treatment of
Recruiting
- Chronic Hepatitis b Patients
- Tenofovir Disoproxil Fumarate and Entcavir
-
Sohag, EgyptSohag University hospitals
May 22, 2023
Chronic Hepatitis Delta Virus Infection Trial (HH-003(20mg/kg), HH-003(10mg/kg), TAF)
Not yet recruiting
- Chronic Hepatitis Delta Virus Infection
- HH-003(20mg/kg)
- +2 more
- (no location specified)
May 7, 2023
Colorectal Cancer, Colorectal Carcinoma, Colorectal Adenocarcinoma Trial run by the NCI (Durvalumab, Tremelimumab, Pexa-Vec)
Active, not recruiting
- Colorectal Cancer
- +4 more
- Durvalumab
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 24, 2023
Malnutrition, Hepatitis B,Chronic, Acute-On-Chronic Liver Failure Trial in Guangzhou (Individual nutritional support)
Recruiting
- Malnutrition
- +3 more
- Individual nutritional support
-
Guangzhou, Guangdong, ChinaThird Affiliated Hospital of Sun Yat-sen University
Nov 9, 2023
COVID-19, Influenza Trial in United States (Lucira COVID-19 & Flu Test)
Completed
- COVID-19
- Influenza
- Lucira COVID-19 & Flu Test
-
Cullman, Alabama
- +6 more
Nov 16, 2023
Influenza A H1N1 Trial in London (Infectious Titre 1, Infectious Titre 2, Infectious Titre 3)
Recruiting
- Influenza A H1N1
- Infectious Titre 1
- +3 more
-
London, United KingdomhVIVO Services Ltd
Oct 6, 2022
Hepatitis B Trial (HH-006, Placebo)
Recruiting
- Hepatitis B
- HH-006
- Placebo
-
Brisbane, Queensland, AustraliaQ-Pharm Pty Ltd (Nucleus Network Pty Ltd)
Dec 22, 2022
Chronic Hepatitis B Virus Infection Trial in Worldwide (PEG-IFNa, BRII-835)
Not yet recruiting
- Chronic Hepatitis B Virus Infection
- PEG-IFNα
- BRII-835
-
Kingswood, New South Wales, Australia
- +28 more
Jul 21, 2023
Diffuse Large B-cell Lymphoma, High-Grade B-cell Lymphoma Trial in Worldwide (RO6870810, Venetoclax, Rituximab)
Completed
- Diffuse Large B-cell Lymphoma
- High-Grade B-cell Lymphoma
- RO6870810
- +2 more
-
Duarte, California
- +8 more
Jan 21, 2022
Influenza A, Influenza Type B, Coronavirus Disease 2019 Trial in Ballarat (LIAISON NES FLU A/B & COVID-19)
Not yet recruiting
- Influenza A
- +2 more
- LIAISON NES FLU A/B & COVID-19
-
Ballarat, Victoria, AustraliaGrampians Health
Jun 7, 2023
Chronic Hepatitis B Trial in Guangzhou (NrtIs, HH-003, HH-003+NrtIs)
Active, not recruiting
- Chronic Hepatitis B
- NrtIs
- +2 more
-
Guangzhou, Guangdong, ChinaNanfang Hospital, Southern Medical University
Apr 20, 2023
Chronic HBV Infection Trial in China (HH-003 injection, Placebo)
Completed
- Chronic HBV Infection
- HH-003 injection
- Placebo
-
Beijing, Beijing, China
- +10 more
Sep 14, 2022
Hepatocellular Carcinoma Trial (Lenvatinib at a dose of 8 mg or 12 mg based on body weight + tislelizumab for one 21-day cycle)
Not yet recruiting
- Hepatocellular Carcinoma
- Lenvatinib at a dose of 8 mg or 12 mg based on body weight + tislelizumab for one 21-day cycle
- (no location specified)
Jun 12, 2023
COVID-19 Respiratory Infection, Influenza A, Influenza Type B Trial in Pasadena (Labcorp COVID-19+Flu+RSV Test Home Collection
Recruiting
- COVID-19 Respiratory Infection
- +3 more
- Labcorp COVID-19+Flu+RSV Test Home Collection Kit
-
Pasadena, CaliforniaExer Urgent Care
Aug 21, 2023
Danon Disease Trial in La Jolla, Philadelphia (RP-A501)
Recruiting
- Danon Disease
- RP-A501
-
La Jolla, California
- +1 more
Oct 17, 2023